Article | August 4, 2009

Policy Shift On Stem Cell Research May Produce Effect Overseas

Source: Life Science Leader

By Ann Roberts Brice, Life Science Leader magazine

Some countries in Europe and elsewhere are looking ahead for opportunities that might emerge from the recent public policy change in the United States that allows federal funding of embryonic stem cell research. Industry experts expect the stem cell industry to flourish in the favorable environment they see developing.

The National Institutes of Health (NIH) set July 7 as its target date for finalizing its Draft Guidelines for Human Stem Cell Research, although no major changes are anticipated.

The draft was released for public comment after the President issued an order in March that reversed a prior ban restricting federal funding for embryonic stem cell research.

The guidelines discuss acceptable use of stem cells derived from embryos created by in vitro fertilization (IVF) for reproductive purposes and no longer needed for those purposes. According to the NIH, the guidelines will try to ensure that such use is “ethically responsible, scientifically worthy, and in accord with applicable law.” The guidelines also describe the conditions and informed consent procedures required during the derivation of such embryonic stem cells.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: